Mclean Hospital

In the Media: Esketamine Effective and Costly Treating Treatment-Resistant Depression

July 14, 2020

HCP Live

Dr. Eric L. Ross and collaborators examine the cost-effectiveness of esketamine, a novel intranasally dosed antidepressant for patients with treatment-resistant depression.

Back to top